Potential 166Ho radiopharmaceuticals for intravascular radiation therapy (IVRT)-I : [166Ho] holmium labeled ethylene dicysteine

This publication has 12 references indexed in Scilit:

• 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy
  Nuclear Medicine Communications, 2000
• [186/188Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy
  Nuclear Medicine and Biology, 2000
• Rhenium-188-labeled DTPA: a new radiopharmaceutical for intravascular radiation therapy
  Nuclear Medicine and Biology, 1999
• Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate
  Nuclear Medicine Communications, 1998
• Advances in Coronary Angioplasty
  New England Journal of Medicine, 1996
• The dose distribution produced by a ³²P‐coated stent
  Medical Physics, 1995
• Processing of reactor-produced 188W for fabrication of clinical scale alumina-based 188W/188Re generators
  Applied Radiation and Isotopes, 1994
• Clinical trials of restenosis after coronary angioplasty.
  Circulation, 1991
• Short lived radionuclides in therapy
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
• Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV. Interaction of 99mTc-DMS and 99Tc-DMS complexes with blood serum proteins
  European Journal of Nuclear Medicine and Molecular Imaging, 1984